# Second Revision Integration Change Log

Generated: 2026-06-14

## Output Files

- `Response_to_Reviewers_Second_Revision.docx`: formal second-revision response letter.
- `Manuscript_Second_Revision_Clean.docx`: clean revised manuscript generated from the clean first-revision manuscript.
- `Supporting_information_Second_Revision.docx`: supporting information with added second-revision baseline/calibration/DCA appendix and captions.
- `Response_to_Reviewers_Second_Revision.md`: editable markdown mirror of the response letter.
- `Strict_Consistency_Audit.md`: automated consistency checks.

## Main Manuscript Changes

- Rewrote the Abstract to define the study as single-center, retrospective, exploratory, and internally validated.
- Clarified that the final multimodal model AUC = 0.816 is an internal cross-validation result.
- Added the newly verified classical clinical baseline comparison: gradient boosting AUC 0.636 (95% CI 0.548-0.718), Brier 0.223, MCC 0.172; repeated CV mean AUC 0.628 +/- 0.084.
- Added calibration and decision-curve analysis text for optimized classical clinical baselines only.
- Added explicit limitation language for missing intraoperative variables: warm ischemia time, pneumoperitoneum pressure/duration, intraoperative hypotension, blood loss, operative duration, fluid balance, vasopressor exposure, and nephrotoxic exposure.
- Tempered SHAP language to descriptive model-attribution wording.
- Added S1-S3 Table and S1-S4 Fig supporting-information captions.

## Interpretation Guardrails

- Do not describe any new analysis as external validation.
- Do not claim final multimodal-model calibration or DCA unless final multimodal probabilities are separately analyzed.
- Do not state that clinical deployment or proven clinical utility has been demonstrated.
- Distinguish the main 194-patient multimodal cohort from the 193-patient tabular classical-baseline analytic set.
